Europe Sinus Tissue Resection Market Size and Share - Growth Analysis Report and Forecast Trends 2026-2030

Sinus tissue resection refers to the set of instruments and techniques used to excise diseased sinus mucosa, polyps or bone during ENT surgery. The European market is currently valued at approximately $1.17 billion in 2025 and is projected to grow at a compound annual rate of about 6.7% through the end of the decade. Growth is concentrated in endoscopic systems, ethmoid forceps, nasal scissors and curettes, which together form the core product portfolio for routine FESS procedures.

• •2025 market value: ~$1.17 billion with a 6.7% CAGR through 2030.
• •Core products include endoscopes, ethmoid forceps, nasal scissors and curettes.
• •Hospitals and specialty ENT clinics are the principal end-use channels.

The principal driver is the steady rise in chronic rhinosinusitis cases across Europe, linked to air pollution, allergen exposure and an aging population. Broader adoption of minimally invasive FESS, supported by better imaging and instrumentation, is also accelerating procedure volumes. Reimbursement coverage for sinus surgery in major public health systems and ongoing training of ENT surgeons further support market expansion.

• •Rising prevalence of chronic rhinosinusitis across Western and Southern Europe.
• •Shift toward minimally invasive endoscopic sinus surgery.
• •Favorable reimbursement and expanding ENT surgeon training programs.

By product, endoscopes account for the largest share, followed by hand instruments such as ethmoid forceps, nasal scissors and curettes; by end-use, hospitals lead, with ambulatory clinics gaining ground. Geographically, Western Europe dominates revenue, led by Germany, France, the UK, Italy and Spain, while Central and Eastern European countries are emerging growth areas as surgical capacity modernizes.

• •Endoscopes remain the leading product category by revenue.
• •Germany, France, the UK, Italy and Spain are the top country markets.
• •Central and Eastern Europe represent the fastest-growing regional segment.

What are the recent trends and outlook?

Key trends include the development of powered and robotic-assisted resection tools, growth of single-use sterile instruments to reduce infection risk, and integration of advanced imaging such as 3D endoscopy and image-guided navigation. Looking ahead, the market is expected to maintain mid-to-high single-digit growth through 2030, supported by procedure volume growth, technology upgrades and expanding access in emerging European markets.

• •Adoption of powered, robotic and image-guided resection systems is accelerating.
• •Demand is rising for single-use and sterile ENT instruments.
• •Sustained 6-7% annual growth is expected through 2030, with Eastern Europe catching up.